Skip to content
drillr.ai
Sign up

BBNX

Beta Bionics, Inc.

NASDAQ · Healthcare · Medical - Equipment & Services · US

$21.89
+2.15%
Ask drillr

  • Sep 17, 2026, 11:26 UTC

    Beta Bionics, Inc. (BBNX) shares surged 15.3% in the prior trading session on above-average trading volume.

    Source:

  • Sep 16, 2026, 14:41 UTC

    Beta Bionics priced a public offering of 7,652,175 common shares at $17.25 per share, plus 1,043,484 pre-funded warrants at $17.2499 each, to raise about $150 million before expenses, expected to close around September 17.

    Source:

  • Sep 15, 2026, 20:13 UTC

    Beta Bionics, Inc. announced a proposed underwritten public offering of $125.0 million of its common stock, with a 30-day underwriter option for up to an additional $18.75 million of shares.

    Source:

  • Sep 14, 2026, 11:30 UTC

    Beta Bionics received U.S. FDA clearance for its Mint patch pump, a reusable and disposable insulin delivery device with CGM integration and smartphone control.

    Source:

  • Sep 14, 2026, 11:00 UTC

    Senseonics Holdings announced a strategic partnership with Beta Bionics to integrate the Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas, with a planned commercial launch in Q4 2026.

    Source:

  • Sep 12, 2026, 01:15 UTC

    Kaplan Fox & Kilsheimer LLP announced that a class action lawsuit has been filed against Beta Bionics, Inc. on behalf of investors who acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026.

    Source:

  • Sep 11, 2026, 18:30 UTC

    Law Offices of Howard G. Smith filed a securities class action on behalf of investors who purchased Beta Bionics, Inc. securities between July 30, 2025 and February 24, 2026, with a lead plaintiff motion deadline of November 3, 2026.

    Source:

  • Sep 11, 2026, 14:13 UTC

    Grabar Law Office announced an investigation into claims on behalf of long-term shareholders of Beta Bionics, Inc. (NASDAQ: BBNX).

    Source:

  • Sep 8, 2026, 21:31 UTC

    A securities class action lawsuit was filed in the United States District Court for the Central District of California on behalf of investors who purchased Beta Bionics, Inc. common stock between July 30, 2025 and February 24, 2026.

    Source:

  • Sep 8, 2026, 05:30 UTC

    A class action lawsuit was filed against Beta Bionics, Inc. for alleged securities law violations under the Securities Exchange Act of 1934.

    Source:

  • Jul 29, 2026, 20:02 UTC

    Beta Bionics reported its financial results for the second quarter of 2026 and updated its full year 2026 guidance.

    Source: